Relationship between genetic variation in the glutaminase gene GLS1 and brain glutamine/glutamate ratio measured in vivo

Biological Psychiatry

Volumn 70, Issue 2, 2011, Pages 169-174

  Öngür, Dost ^a,b   Haddad, Stephen ^c   Prescot, Andrew P ^d   Jensen, J Eric ^a,b   Siburian, Richie ^c   Cohen, Bruce M ^a,b   Renshaw, Perry F ^d   Smoller, Jordan W ^b,c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

J resolved; magnetic resonance spectroscopy (MRS); megapress; neurotransmission

Indexed keywords

DNA; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE;

ADULT; ARTICLE; BRAIN; BRAIN LEVEL; CINGULATE GYRUS; CLINICAL ARTICLE; FEMALE; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GLS1 GENE; HAPLOTYPE; HUMAN; IN VIVO STUDY; MALE; MENTAL DISEASE; NEUROTRANSMISSION; OCCIPITAL CORTEX; PARIETAL CORTEX; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CEREBRAL CORTEX; CHROMOSOMES, HUMAN, PAIR 2; DATABASES, FACTUAL; FEMALE; GENOTYPE; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTONS;

EID: 79959721561     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.01.033     Document Type: Article

References (52)

1. A. Schousboe, and H.S. Waagepetersen Role of astrocytes in glutamate homeostasis: Implications for excitotoxicity Neurotox Res 8 2005 221 225
2. P.J. Magistretti, and L. Pellerin The astrocyte-mediated coupling between synaptic activity and energy metabolism operates through volume transmission Prog Brain Res 125 2000 229 240 (Pubitemid 35460801)
3. J.E. Jensen, S.C. Licata, D. Ongur, S.D. Friedman, A.P. Prescot, M.E. Henry, and P.F. Renshaw Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla NMR Biomed 22 2009 762 769
4. S. Posse, R. Otazo, A. Caprihan, J. Bustillo, H. Chen, and P.G. Henry Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla Magn Reson Med 58 2007 236 244 (Pubitemid 47267640)
5. R.F. Schulte, T. Lange, J. Beck, D. Meier, and P. Boesiger Improved two-dimensional J-resolved spectroscopy NMR Biomed 19 2006 264 270
6. S. Xu, J. Yang, C.Q. Li, W. Zhu, and J. Shen Metabolic alterations in focally activated primary somatosensory cortex of alpha-chloralose-anesthetized rats measured by 1H MRS at 11.7 T Neuroimage 28 2005 401 409 (Pubitemid 41443509)
7. H. Igarashi, I.L. Kwee, T. Nakada, Y. Katayama, and A. Terashi 1H magnetic resonance spectroscopic imaging of permanent focal cerebral ischemia in rat: Longitudinal metabolic changes in ischemic core and rim Brain Res 907 2001 208 221 (Pubitemid 32595530)
8. V. Mlynarik, I. Kohler, G. Gambarota, A. Vaslin, P.G. Clarke, and R. Gruetter Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra-short echo times Magn Reson Med 59 2008 52 58
9. I. Iltis, D.M. Koski, L.E. Eberly, C.D. Nelson, D.K. Deelchand, and J. Valette Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: An in vivo localized (1)H MRS study NMR Biomed 22 2009 737 744
10. L.M. Rowland, J.R. Bustillo, P.G. Mullins, R.E. Jung, R. Lenroot, and E. Landgraf Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study Am J Psychiatry 162 2005 394 396 (Pubitemid 40216226)
11. F. Ghoddoussi, M.P. Galloway, A. Jambekar, M. Bame, R. Needleman, and W.S. Brusilow Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS J Neurol Sci 290 2010 41 47
12. J.T. Coyle Glutamate and schizophrenia: Beyond the dopamine hypothesis Cell Mol Neurobiol 26 2006 365 384
13. J.H. Krystal, G. Sanacora, H. Blumberg, A. Anand, D.S. Charney, and G. Marek Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments Mol Psychiatry 7 2002 S71 S80
14. D.C. Javitt Glutamate as a therapeutic target in psychiatric disorders Mol Psychiatry 9 2004 984 997 979 (Pubitemid 39524288)
15. C.A. Zarate Jr, and H.K. Manji Bipolar disorder: Candidate drug targets Mt Sinai J Med 75 2008 226 247
16. G. Sanacora, C.A. Zarate, J.H. Krystal, and H.K. Manji Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nat Rev Drug Discov 7 2008 426 437 (Pubitemid 351619114)
17. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, and B.V. Andreev Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized phase 2 clinical trial Nat Med 13 2007 1102 1107 (Pubitemid 47517511)
18. P.J. Conn, C.W. Lindsley, and C.K. Jones Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia Trends Pharmacol Sci 30 2009 25 31
19. C.A. Zarate Jr, J.A. Quiroz, J.B. Singh, K.D. Denicoff, G. De Jesus, and D.A. Luckenbaugh An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression Biol Psychiatry 57 2005 430 432 (Pubitemid 40215774)
20. D. Ongur, J.E. Jensen, A.P. Prescot, C. Stork, M. Lundy, B.M. Cohen, and P.F. Renshaw Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania Biol Psychiatry 64 2008 718 726
21. B.P. Brennan, J.I. Hudson, J.E. Jensen, J. McCarthy, J.L. Roberts, and A.P. Prescot Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole Neuropsychopharmacology 35 2010 834 846
22. M. Walter, A. Henning, S. Grimm, R.F. Schulte, J. Beck, and U. Dydak The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression Arch Gen Psychiatry 66 2009 478 486
23. J. Theberge, R. Bartha, D.J. Drost, R.S. Menon, A. Malla, and J. Takhar Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers Am J Psychiatry 159 2002 1944 1946 (Pubitemid 35283267)
24. J.R. Bustillo, L.M. Rowland, P. Mullins, R. Jung, H. Chen, and C. Qualls (1)H-MRS at 4 Tesla in minimally treated early schizophrenia Mol Psychiatry 15 2009 629 636
25. M.R. Gluck, R.G. Thomas, K.L. Davis, and V. Haroutunian Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients Am J Psychiatry 159 2002 1165 1173 (Pubitemid 34743257)
26. P.V. Choudary, M. Molnar, S.J. Evans, H. Tomita, J.Z. Li, and M.P. Vawter Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression Proc Natl Acad Sci U S A 102 2005 15653 15658 (Pubitemid 41528111)
27. E.G. Bruneau, R.E. McCullumsmith, V. Haroutunian, K.L. Davis, and J.H. Meador-Woodruff Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia Schizophr Res 75 2005 27 34 (Pubitemid 40487971)
28. A. Sequeira, F. Mamdani, C. Ernst, M.P. Vawter, W.E. Bunney, and V. Lebel Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression PLoS ONE 4 2009 e6585
29. A. Sequeira, and G. Turecki Genome wide gene expression studies in mood disorders OMICS 10 2006 444 454 (Pubitemid 46174578)
30. S.R. Marcus, H.A. Nadiger, M.V. Chandrakala, T.I. Rao, and B. Sadasivudu Acute and short-term effects of lithium on glutamate metabolism in rat brain Biochem Pharmacol 35 1986 365 369 (Pubitemid 16139456)
31. I. Gaisler-Salomon, G.M. Miller, N. Chuhma, S. Lee, H. Zhang, and F. Ghoddoussi Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: Relevance to schizophrenia Neuropsychopharmacology 34 2009 2305 2322
32. B. Zhang, Y. Yuan, Y. Jia, X. Yu, Q. Xu, Y. Shen, and Y. Shen An association study between polymorphisms in five genes in glutamate and GABA pathway and paranoid schizophrenia Eur Psychiatry 20 2005 45 49 (Pubitemid 40092390)
33. H. Maeshima, T. Ohnuma, Y. Sakai, N. Shibata, H. Baba, and H. Ihara Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophreniaJuntendo University schizophrenia Projects (JUSP) Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1410 1418 (Pubitemid 47302552)
34. J. Marquez, M. Tosina, V. de la Rosa, J.A. Segura, F.J. Alonso, and J.M. Mates New insights into brain glutaminases: Beyond their role on glutamatergic transmission Neurochem Int 55 2009 64 70
35. E. Kvamme, B. Roberg, and I.A. Torgner Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain Neurochem Res 25 2000 1407 1419
36. N.P. Curthoys, and M. Watford Regulation of glutaminase activity and glutamine metabolism Annu Rev Nutr 15 1995 133 159
37. D. Ongur, A.P. Prescot, J. McCarthy, B.M. Cohen, and P.F. Renshaw Elevated gamma-aminobutyric acid levels in chronic schizophrenia Biol Psychiatry 68 2010 667 670
38. M. Mescher, H. Merkle, J. Kirsch, M. Garwood, and R. Gruetter Simultaneous in vivo spectral editing and water suppression NMR Biomed 11 1998 266 272 (Pubitemid 28465190)
39. P.I. de Bakker, R. Yelensky, I. Pe'er, S.B. Gabriel, M.J. Daly, and D. Altshuler Efficiency and power in genetic association studies Nat Genet 37 2005 1217 1223 (Pubitemid 41568704)
40. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender PLINK: A tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575 (Pubitemid 47330214)
41. G. Sanacora, R. Gueorguieva, C.N. Epperson, Y.T. Wu, M. Appel, and D.L. Rothman Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression Arch Gen Psychiatry 61 2004 705 713 (Pubitemid 38890805)
42. D. Ongur, A. Prescot, J.M. McCarthy, B.M. Cohen, and P.F. Renshaw Elevated gamma-aminobutyric acid levels in chronic schizophrenia Biol Psychiatry 68 2010 667 670
43. T.U. Woo, J.P. Walsh, and F.M. Benes Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder Arch Gen Psychiatry 61 2004 649 657 (Pubitemid 38890797)
44. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, S. Heckers, and A.A. Grace Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci 31 2008 234 242
45. J. Theberge, K.E. Williamson, N. Aoyama, D.J. Drost, R. Manchanda, and A.K. Malla Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia Br J Psychiatry 191 2007 325 334 (Pubitemid 47555981)
46. D. ngr, W.C. Drevets, and J.L. Price Glial reduction in the subgenual prefrontal cortex in mood disorders Proc Natl Acad Sci U S A 95 1998 13290 13295 (Pubitemid 28509564)
47. D.R. Cotter, C.M. Pariante, and I.P. Everall Glial cell abnormalities in major psychiatric disorders: The evidence and implications Brain Res Bull 55 2001 585 595 (Pubitemid 32888377)
48. G. Rajkowska, A. Halaris, and L.D. Selemon Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder Biol Psychiatry 49 2001 741 752 (Pubitemid 32452295)
49. N. Sailasuta, O. Abulseoud, K.C. Harris, and B.D. Ross Glial dysfunction in abstinent methamphetamine abusers J Cereb Blood Flow Metab 30 2009 950 960
50. M. Banasr, and R.S. Duman Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors Biol Psychiatry 64 2008 863 870
51. A.J. Bechtholt-Gompf, H.V. Walther, M.A. Adams, W.A. Carlezon, D. ngr, and B.M. Cohen Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia without dysphoria and impaired spatial memory Neuropsychopharmacology 35 2010 2049 2059
52. M. Banasr, G.M. Chowdhury, R. Terwilliger, S.S. Newton, R.S. Duman, K.L. Behar, and G. Sanacora Glial pathology in an animal model of depression: Reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole Mol Psychiatry 15 2008 501 511